A sudden surge in Eastman Kodak Co.’s stock this week has turned a bunch of money-losing executive stock-option grants made in the past two years—including some made on Monday—into a sudden personal windfall for the company’s executive chairman.
On Tuesday, Kodak and the U.S. government announced a preliminary agreement under which the firm would receive a loan to produce drug ingredients. The news has since led the one-time photography giant’s share price to more than triple.
…
Comments are closed